“…[23] Current targeting strategies involve the use of antibodies, [24] aptamers, [25] or small molecules such as vancomycin. [34,35] Multivalent glycoconjugates, such as glycoclusters, glycopeptides, and glyconanoparticles, have been employed as lectin ligands for inhibition of bacterial adhesion and biofilm formation, [36][37][38][39][40] decontamination of bacteria, [41] and blockage of host cell invasion by bacteria. [27][28][29] Numerous strains of bacteria express carbohydrate-binding proteins, termed lectins, on their surfaces to mediate critical physiological and pathological activities, for example, adhesion to host cells, biofilm formation, and infection.…”